Evidence map›Paper›PMID 35081148›Full record

ArticlePloS one2022

Detection of breast cancer by ATR-FTIR spectroscopy using artificial neural networks.

Rock Christian Tomas, Anthony Jay Sayat, Andrea Nicole Atienza, Jannah Lianne Danganan, Ma Rollene Ramos, Allan Fellizar, Kin Israel Notarte, Lara Mae Angeles, Ruth Bangaoil, Abegail Santillan and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
11.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review: Detection of Cancer Biomarkers from a Clinical Perspective.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Rock Christian TomasDepartment of Electrical Engineering, University of the Philippines Los Baños, Los Baños, Laguna, Philippines.ORCID 0000-0001-9800-8104
Anthony Jay SayatDepartment of Biological Sciences, College of Science, University of Santo Tomas, Manila, Philippines.
Andrea Nicole AtienzaDepartment of Biological Sciences, College of Science, University of Santo Tomas, Manila, Philippines.
Jannah Lianne DangananDepartment of Biological Sciences, College of Science, University of Santo Tomas, Manila, Philippines.
Ma Rollene RamosDepartment of Biological Sciences, College of Science, University of Santo Tomas, Manila, Philippines.
Allan FellizarResearch Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines.
Kin Israel NotarteFaculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.ORCID 0000-0002-6055-0886
Lara Mae AngelesFaculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
Ruth BangaoilResearch Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines.ORCID 0000-0002-7329-4594
Abegail SantillanResearch Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines.
Pia Marie AlbanoDepartment of Biological Sciences, College of Science, University of Santo Tomas, Manila, Philippines.ORCID 0000-0002-5024-8819
University of Santo Tomas · PHMariano Marcos State University · PHUniversity of Santo Tomas Hospital · PHUniversity of the Philippines Los Baños · PH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, three (3) neural networks (NN) were designed to discriminate between malignant (n = 78) and benign (n = 88) breast tumors using their respective attenuated total reflection Fourier transform infrared (ATR-FTIR) spectral data. A proposed NN-based sensitivity analysis was performed to determine the most significant IR regions that distinguished benign from malignant samples. The result of the NN-based sensitivity analysis was compared to the obtained results from FTIR visual peak identification. In training each NN models, a 10-fold cross validation was performed and the performance metrics-area under the curve (AUC), accuracy, positive predictive value (PPV), specificity rate (SR), negative predictive value (NPV), and recall rate (RR)-were averaged for comparison. The NN models were compared to six (6) machine learning models-logistic regression (LR), Naïve Bayes (NB), decision trees (DT), random forest (RF), support vector machine (SVM) and linear discriminant analysis (LDA)-for benchmarking. The NN models were able to outperform the LR, NB, DT, RF, and LDA for all metrics; while only surpassing the SVM in accuracy, NPV and SR. The best performance metric among the NN models was 90.48% ± 10.30% for AUC, 96.06% ± 7.07% for ACC, 92.18 ± 11.88% for PPV, 94.19 ± 10.57% for NPV, 89.04% ± 16.75% for SR, and 94.34% ± 10.54% for RR. Results from the proposed sensitivity analysis were consistent with the visual peak identification. However, unlike the FTIR visual peak identification method, the NN-based method identified the IR region associated with C-OH C-OH group carbohydrates as significant. IR regions associated with amino acids and amide proteins were also determined as possible sources of variability. In conclusion, results show that ATR-FTIR via NN is a potential diagnostic tool. This study also suggests a possible more specific method in determining relevant regions within a sample's spectrum using NN.

Indexed as

Breast NeoplasmsFemaleHumansLogistic ModelsNeural Networks, ComputerSensitivity and SpecificitySpectroscopy, Fourier Transform Infrared

Identifiers

PMID35081148
PMCPMC8791515
OpenAlexW4210531825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.